Top

Published in:

01-09-2016 | Original Article

The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine

Authors: Narges Khabazzadeh Tehrani, Mehdi Mahdavi, Fatemeh Maleki, Somayeh Zarrati, Fatemeh Tabatabaie

Published in: Journal of Parasitic Diseases | Issue 3/2016

Abstract

Leishmaniasis is a parasitic disease caused by several species of the genus Leishmania. Montanide ISA 70 is an adjuvant composed of a natural metabolizable oil and a very refined emulsifier from the manide monooleate family. The TSA (thiol-specific antioxidant) is a important antigen of Leishmania major. The purpose of this work was protein-vaccine efficacy as an protection and excellent candidate in the presence Montanide. The expression of recombinant protein was confirmed with SDS (sodium dodecyl sulfate) page and Western bloting. 48 BALB/c mice were divided into four groups (TSA/Freund,TSA/Alum + BCG, TSA/Montanide and PBS groups) and immunized with 20 μg of vaccine subcutaneously three times intervals on days 0, 14 and 28. The mice were challenged with parasite 21 days after final immunization. The lymphocyte proliferation was evaluated with Brdu method. Cytokines and also total antibody and subclasses were evaluated with ELISA method. The vaccine formulated with the recombinant TSA protein with Montanide induced lymphocytes proliferation cytokines and total antibody and subclasses as compared with the control group.

Ahmed SB, Bahloul C, Robbana C, Askri S, Dellagi KA (2004) Comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L.major. Vaccine 22:1631–1639CrossRefPubMed

Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671CrossRefPubMedCentralPubMed

Aucouturier J, Dupuis L, Ganne V (2001) Adjuvants designed for veterinary and human vaccines. Vaccine 19:2666–2672CrossRefPubMed

Aucouturier J, Dupuis L, Deville S, Ascarateil S, Ganne V (2002) Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vaccines 1:111–118CrossRefPubMed

Benhnini F, Chenik M, Laouini D, Louzir H, Cazenave PA, Dellagi K (2009) Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains. Clin Vaccine Immunol 16:1529–1537CrossRefPubMedCentralPubMed

Bradford, MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMed

Buffer PA, Sulahian A, Garin YJF, Nassar N, Derouin F (1995) Culture microtitration :a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 216:7–8

Campos-Neto A (2005) What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery? Braz j Med Biol Res = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al]; 38:979–984

Campos-Neto A, Porrozzi R, Greeson K, Coler RN, Webb JR, Seiky YA et al (2001) Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect Immun 69:4103–4108CrossRefPubMedCentralPubMed

Campos-Neto A, Webb JR, Greeson K, Coler RN, Skeiky YA, Reed SG (2002) Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice. Infect Immun 70:2828–2836CrossRefPubMedCentralPubMed

Chae HZ, Kim IH, Kim K, Rhee SG (1993) Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem 268:16815–16821PubMed

Chae HZ, Chung SJ, Rhee SG (1994a) Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 269:27670–27678PubMed

Chae HZ, Robison K, Poole LB, Church G, Storz G, Rhee SG (1994b) Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 91:7017–7021CrossRefPubMedCentralPubMed

Coler, RN, Reed, SG (2005) Second-generation vaccines against leishmaniasis. Trends Parasitol 21:244–249CrossRefPubMed

Douba MD, Abbas O, Wali A, Nassany J, Aouf A, Tibbi MS et al (2012) Chronic cutaneous leishmaniasis, a great mimicker with various clinical presentations: 12 years experience from Aleppo. J Eur Acad Dermatol Venereol 26:1224–1229CrossRefPubMed

Farahmand M, Nahrevanian H, Shirazi HA, Naeimi S, Farzanehnejad Z (2011) An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran. Braz J Infect Dis 15:17–21CrossRefPubMed

Handman E (2001) Leishmaniasis :current status of vaccine development. Clin Microbiol Rev 14:229–243CrossRefPubMedCentralPubMed

James SL, Nacy C (1993) Effector functions of activated macrophages against parasites. Curr Opin Immunol 5:518–523CrossRefPubMed

Joshua MM, John CM, Michael MG (2010) A review of adjuvants for leishmania vaccine candidates. J Biomed Res 24:16–25CrossRef

Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F (2006) Leishmaniasis vaccine candidates for development: a global overview. IndianJ Med Res 123:423–438

Khoshgoo N, Zahedifarda F, Azizia H, Taslimia Y, Alonsoc MJ, Rafati S (2008) Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals. Vaccine 26:5822–5829CrossRefPubMed

Masina S, Gicheru MM, Demotz SO, Fasel NJ (2003) Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen. J Infect Dis 15:1250–1257CrossRef

Mauel J (2002) Vaccination against Leishmania infections. Curr Drug Targets Immune Endocr Metabol Disord 2:201–226CrossRefPubMed

Mehlotra, RK (1996) Antioxidant defense mechanisms in parasitic protozoa. Crit Rev Microbiol 22:295–314CrossRefPubMed

Mendez S, Belkaid Y, Seder RA, Sacks D, Sender R (2002) Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine 20:3702–3708CrossRefPubMed

Mougneau E, Altare F, Wakil AE, Zheng S, Coppola T, Wang ZE et al (1995) Expression cloning of a protective Leishmania antigen. Science 268:563CrossRefPubMed

Netto, LES, Chae,H.Z, Kang, SW, Rhee,S.G, Stadtman, ER (1996) Removal of hydrogen peroxide by thiol-specific antioxidant enzyme [TSA] is involved with its antioxidant properties. TSA possesses thiol peroxidase activity. J Biol Chem 271:15315–15321CrossRef

Ovendale PJ, Martin TI, Webb JR, Campos-Neto A, Reed SG, Badaro R et al (1998) Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect Immun 66:3279–3289PubMedCentralPubMed

Qiu Q, Yuan-HuWang R, Jiao X, Jin B, Sugauchi F, Grandinetti T et al (2008) Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants. Vaccine 26:5527–5534CrossRefPubMedCentralPubMed

Rafati S, Zahedifard F, Nazgouee F (2006) Prime–boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis. Vaccine 24:2169–2175CrossRefPubMed

Rosado-Vallado M, Mut-Martin M, Garsia-Miss M, Dumonteil E (2005) Aluminium phosphate potentiates the efficacy of DNA vaccine against Leishmania Mexicana. Vaccine 23:5372–5379CrossRefPubMed

Sasaki S, Takeshita F, Xin KQ, Ishii N, Okuda K (2003) Adjuvant formulation and delivery systems for DNA vaccines. Methods 31:243–254CrossRefPubMed

Tabatabaie F, Ghaffari far F, Dalimi A, Sharifi Z, Zavaran Hoseini A (2007) Cloning and sequencing of leishmania major thiol-specific antioxidant antigen [TSA] gene. Iran J Parasitol 2:30–41

Toledo H, Baly A, Castro O, Resik S, Laferte J, Rolo F et al (2001) A phase I clinical trial of a multi-epitope polypeptide TAB 9 combined with Montanide ISA720 adjuvant in non-HIV-1 infected human volunteers. Vaccine 19:4328–4336CrossRefPubMed

Von Stebut E (2007) Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 17:115–122

Webb JR, Campos-Neto A, Ovendale PJ, Martin TI, Stromberg EJ, Badaro R et al (1998) Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect Immun 66:3279–3289PubMedCentralPubMed

Title: The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine
Authors: Narges Khabazzadeh Tehrani
Mehdi Mahdavi
Fatemeh Maleki
Somayeh Zarrati
Fatemeh Tabatabaie
Publication date: 01-09-2016
Publisher: Springer India
Published in: Journal of Parasitic Diseases / Issue 3/2016
Print ISSN: 0971-7196
Electronic ISSN: 0975-0703
DOI: https://doi.org/10.1007/s12639-014-0574-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Histopathological and bacterial study of skin and gill of grass carp, Ceteopharyngodon idella, (Valenciennes 1844) exposed to copper sulfate and potassium permanganate

Endoparasites of some economically important food fishes of River Jhelum, Kashmir (India)

Effects of Toxoplasma gondii infection on anxiety, depression and ghrelin level in male rats

Comparison of microscopic and immunoassay examination in the diagnosis of intestinal protozoa of humans in Mansoura, Egypt

Evaluation of modified Ziehl–Neelsen, direct fluorescent-antibody and PCR assay for detection of Cryptosporidium spp. in children faecal specimens

Cross sectional epidemiological investigation on the prevalence of gastrointestinal helminths in free range chickens in Narsingdi district, Bangladesh

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page